Enliven Therapeutics, Inc. ELVN
Set alert
45.15 USD +0.52 +1.17%
As of Nov 3, 2:31 PM ET
45.05 Day range 45.90
14.79 52-week range 62.32
- YTD
- +193.18%
- 1 year
- +125.75%
- Open
- 45.25
- Prev close
- 44.63
- Mkt cap
- 3.31B
- Vol
- 246.55K
- Avg vol
- 1.33M
- EPS
- -1.67
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 45.05
- High
- 45.90
- Forward P/E
- -19.26
- Beta
- 0.36
- Short ratio
- 5.98
- Inst. own
- 115.72%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 11, 2026
- 50-d avg
- 48.70
- 200-d avg
- 42.73
- 1y target
- 74.42
MAX chart
Events in this range
- Aug 13, 2025Earnings: -0.49; estimate -0.53; surprise 7.55%
- Nov 12, 2025Earnings: -0.32; estimate -0.43; surprise 25.58%
- Mar 3, 2026Earnings: -0.48; estimate -0.42; surprise -14.29%
- May 7, 2026Earnings: -0.38; estimate -0.44; surprise 13.64%
- Aug 5, 2026Earnings: -0.49; estimate -0.38717; surprise -26.56%
- Aug 18, 2026Rating: Mizuho · Outperform → Outperform
- Aug 18, 2026Rating: Barclays · — → Overweight
- Aug 18, 2026Rating: William Blair · — → Outperform
- Oct 1, 2026Rating: JP Morgan · — → Overweight
- Oct 2, 2026Rating: Morgan Stanley · — → Overweight
- Oct 19, 2026Rating: HC Wainwright & Co. · Buy → Buy
Signals (111)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Nov 3, 2026 | 3 hours ago |
| SMA: Bearish | Oct 5, 2026 | 4 weeks ago |
| SMA: Bullish | Sep 28, 2026 | 1 month ago |
| SMA: Bearish | Sep 21, 2026 | 1 month ago |
| SMA: Bearish | Sep 7, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 7, 2026 | 1 month ago |
| RSI: Overbought | Aug 31, 2026 | 2 months ago |
| RSI: Overbought | Jul 27, 2026 | 3 months ago |
| MACD: Buy Signal | Jun 15, 2026 | 4 months ago |
| SMA: Bullish | Jun 8, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 1, 2026 | 5 months ago |
| SMA: Bearish | May 25, 2026 | 5 months ago |
| RSI: Overbought | Mar 23, 2026 | 7 months ago |
| SMA: Bullish | Jan 5, 2026 | 10 months ago |
| SMA: Bullish | Jan 5, 2026 | 10 months ago |
| MACD: Buy Signal | Jan 5, 2026 | 10 months ago |
| SMA: Bearish | Dec 8, 2025 | 11 months ago |
| SMA: Bearish | Dec 8, 2025 | 11 months ago |
| MACD: Sell Signal | Dec 8, 2025 | 11 months ago |
| SMA: Bullish | Nov 10, 2025 | 11 months ago |
Newest 20 of 111.
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 74.42 +64.8% upside
Now 45.15
- Target (low)
- 69.00
- Target (mean)
- 74.42
- Target (high)
- 82.00
Ratings (0m) 14 14 buy · 0 hold · 0 sell
- Strong buy3
- Buy11
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 14
- 1 month ago 12
- 2 months ago 12
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.4522 | -0.52 – -0.38 | -0.32 | -41.3% | 0 | 0.0% | 8 |
| Next quarter | -0.56594 | -0.69 – -0.46 | -0.48 | -17.9% | 0 | 0.0% | 7 |
| Current year | -1.91 | -2.55 – -1.38 | -1.83 | -4.6% | 0 | 0.0% | 8 |
| Next year | -2.32 | -2.60 – -1.94 | -1.91 | -21.1% | 5.00K | 0.0% | 8 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 19, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Oct 2, 2026 | Morgan Stanley | Initiated | — | Overweight |
| Oct 1, 2026 | JP Morgan | Initiated | — | Overweight |
| Aug 18, 2026 | William Blair | Initiated | — | Outperform |
| Aug 18, 2026 | Barclays | Initiated | — | Overweight |
| Aug 18, 2026 | Mizuho | Maintained | Outperform | Outperform |
| Aug 6, 2026 | Stifel | Maintained | Buy | Buy |
| Aug 6, 2026 | Guggenheim | Maintained | Buy | Buy |
| Aug 6, 2026 | Goldman Sachs | Maintained | Buy | Buy |
| Jul 21, 2026 | Goldman Sachs | Maintained | Buy | Buy |
| Jul 9, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Jul 1, 2026 | Stifel | Maintained | Buy | Buy |
| Jun 29, 2026 | Jones Trading | Maintained | Buy | Buy |
| Jun 9, 2026 | Stifel | Initiated | — | Buy |
| Jun 2, 2026 | Mizuho | Maintained | Outperform | Outperform |
| May 8, 2026 | Goldman Sachs | Maintained | Buy | Buy |
| Mar 26, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Mar 25, 2026 | Mizuho | Maintained | Outperform | Outperform |
| Jul 2, 2025 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Jun 16, 2025 | Goldman Sachs | Initiated | — | Buy |
| Jun 16, 2025 | Baird | Maintained | Outperform | Outperform |
| May 16, 2025 | Jones Trading | Maintained | Buy | Buy |
| May 15, 2025 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Mar 21, 2025 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Dec 13, 2024 | BTIG | Initiated | — | Buy |
| Nov 15, 2024 | Baird | Maintained | Outperform | Outperform |
| Oct 31, 2024 | Jones Trading | Initiated | — | Buy |
| Oct 1, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Sep 9, 2024 | HC Wainwright & Co. | Initiated | — | Buy |
| Jun 11, 2024 | Baird | Initiated | — | Outperform |